For Partners
Great science shouldn't stop at one species.
Familiar partners with biopharma, biotech, academic, and technology organizations to translate promising science into new medicines for companion animals. We work across licensing, co-development, research collaborations, and enabling technologies.
WHY FAMILIAR
The value flows both ways.
Companion animal medicine creates a new development and commercial path for science rooted in human biology. Familiar brings the cross-species translation, veterinary regulatory strategy, clinical development, and commercialization focus needed to turn that science into new medicines for animals.
We structure partnerships so originating partners retain meaningful economics while gaining access to this market, and the clinical data that comes with it.
WHAT WE PARTNER ON
Different starting points. One shared goal.
We work with partners across therapeutics, research, and enabling technologies to bring new medicines to companion animals.
Therapeutic programs
Validated human therapeutics and drug candidates with the potential to translate into meaningful veterinary medicines.
Academic science
Promising biology, translational research, and discoveries that could unlock new therapeutics or diagnostics for companion animals.
Enabling technologies
Diagnostics, drug delivery, manufacturing, data, and other technologies that can accelerate or strengthen our pipeline.
HOW WE PARTNER
Flexible ways to work together.
Licensing
We in-license validated human therapeutic programs for development and commercialization in companion animals.
Co-development
We share development work and upside as we run parallel translational, regulatory, and clinical programs.
Research collaborations
We work with academic and scientific partners to translate promising discoveries into veterinary programs.
Strategic collaborations
We partner with technology and development companies whose capabilities can accelerate our pipeline.
Get in touch
Let's explore what a partnership could look like.
We're always interested in meeting teams with great science, promising programs, or technologies that could advance animal health.